Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: Evidence for cGMP-independent mechanisms

Biochemical Pharmacology

Volumn 73, Issue 10, 2007, Pages 1593-1601

  Oberprieler, Nikolaus G ^a   Roberts, Wayne ^a   Graham, Anne M ^a   Homer Vanniasinkam, Shervanthi ^a,b   Naseem, Khalid M ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

ADP; cGMP; Integrin IIb 3; Nitric oxide; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM; CYCLIC GMP; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FIBRINOGEN; NITRIC OXIDE; PENTETIC ACID; PHOSPHOINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; PURINE P2Y1 RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CALCIUM MOBILIZATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; FIBRINOGEN; HUMANS; NITRIC OXIDE; PHOSPHORYLATION; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIGNAL TRANSDUCTION; TYROSINE;

EID: 34047097300     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.01.017     Document Type: Article

References (41)

1. Gao J., Zoller K.E., Ginsberg M.H., Brugge J.S., and Shattil S.J. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. Embo J 16 (1997) 6414-6425
2. Knezevic I., Leisner T.M., and Lam S.C. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alphaIIb and beta3. J Biol Chem 271 (1996) 16416-16421
3. Calderwood D.A., Zent R., Grant R., Rees D.J., Hynes R.O., and Ginsberg M.H. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274 (1999) 28071-28074
4. Furlong B., Henderson A.H., Lewis M.J., and Smith J.A. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90 (1987) 687-692
5. de Graaf J.C., Banga J.D., Moncada S., Palmer R.M., de Groot P.G., and Sixma J.J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85 (1992) 2284-2290
6. Schmidt H.H., Lohmann S.M., and Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178 (1993) 153-175
7. Jensen B.O., Selheim F., Doskeland S.O., Gear A.R., and Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood (2004)
8. Crane M.S., Rossi A.G., and Megson I.L. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations. Br J Pharmacol 144 (2005) 849-859
9. Tsikas D., Ikic M., Tewes K.S., Raida M., and Frolich J.C. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett 442 (1999) 162-166
10. Gordge M.P., Hothersall J.S., and Noronha-Dutra A.A. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br J Pharmacol 124 (1998) 141-148
11. Cavallini L., Coassin M., Borean A., and Alexandre A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 271 (1996) 5545-5551
12. Halbrugge M., Friedrich C., Eigenthaler M., Schanzenbacher P., and Walter U. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem 265 (1990) 3088-3093
13. Danielewski O., Schultess J., and Smolenski A. The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I. Thromb Haemost 93 (2005) 319-325
14. Reid H.M., and Kinsella B.T. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitisation. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin. J Biol Chem 278 (2003) 51190-51202
15. Geiger J., Nolte C., and Walter U. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. Am J Physiol 267 (1994) C236-C244
16. 2+ release from internal stores in human platelets. Br J Pharmacol 119 (1996) 1361-1366
17. Pernollet M.G., Lantoine F., and Devynck M.A. Nitric oxide inhibits ATP-dependent Ca2+ uptake into platelet membrane vesicles. Biochem Biophys Res Commun 222 (1996) 780-785
18. Nguyen B.L., Saitoh M., and Ware J.A. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 261 (1991) H1043-H1052
19. Morgan R.O., and Newby A.C. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets. Biochem J 258 (1989) 447-454
20. 2+ stores. Circ Res 84 (1999) 201-209
21. Pigazzi A., Heydrick S., Folli F., Benoit S., Michelson A., and Loscalzo J. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J Biol Chem 274 (1999) 14368-14375
22. Vargas J.R., Radomski M., and Moncada S. The use of prostacyclin in the separation from plasma and washing of human platelets. Prostaglandins 23 (1982) 929-945
23. Bellavite P., Andrioli G., Guzzo P., Arigliano P., Chirumbolo S., Manzato F., et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 216 (1994) 444-450
24. Marcondes S., Cardoso M.H., Morganti R.P., Thomazzi S.M., Lilla S., Murad F., et al. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for {alpha}-actinin nitration. Proc Natl Acad Sci USA (2006)
25. Moro M.A., Russel R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M., et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 93 (1996) 1480-1485
26. Oelze M., Mollnau H., Hoffmann N., Warnholtz A., Bodenschatz M., Smolenski A., et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 87 (2000) 999-1005
27. Li Z., Ajdic J., Eigenthaler M., and Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 101 (2003) 4423-4429
28. Jin J., Daniel J.L., and Kunapuli S.P. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273 (1998) 2030-2034
29. Dorsam R.T., and Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113 (2004) 340-345
30. Hechler B., Leon C., Vial C., Vigne P., Frelin C., Cazenave J.P., et al. The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 92 (1998) 152-159
31. Turner N.A., Moake J.L., and McIntire L.V. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. Blood 98 (2001) 3340-3345
32. Riba R., Sharifi M., Farndale R.W., and Naseem K.M. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein-VI mediates platelet nitric oxide synthesis in response to collagen. Thromb Haemost 94 (2005) 395-403
33. Keh D., Thieme A., Kurer I., Falke K.J., and Gerlach H. Inactivation of platelet glycoprotein IIb/IIIa receptor by nitric oxide donor 3-morpholino-sydnonimine. Blood Coagul Fibrinolysis 14 (2003) 327-334
34. Michelson A.D., Benoit S.E., Furman M.I., Breckwoldt W.L., Rohrer M.J., Barnard M.R., et al. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol 270 (1996) H1640-H1648
35. Radomski M.W., Palmer R.M., and Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148 (1987) 1482-1489
36. Venturini C.M., Weston L.K., and Kaplan J.E. Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium. Am J Physiol 263 (1992) H606-H612
37. Polanowska-Grabowska R., and Gear A.R. Role of cyclic nucleotides in rapid platelet adhesion to collagen. Blood 83 (1994) 2508-2515
38. Massberg S., Sausbier M., Klatt P., Bauer M., Pfeifer A., Siess W., et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′-monophosphate kinase I. J Exp Med 189 (1999) 1255-1264
39. Morrell C.N., Matsushita K., Chiles K., Scharpf R.B., Yamakuchi M., Mason R.J., et al. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci USA 102 (2005) 3782-3787
40. Naseem K.M., Low S.Y., Sabetkar M., Bradley N.J., Khan J., Jacobs M., et al. The nitration of platelet cytosolic proteins during agonist-induced activation of platelets. FEBS Lett 473 (2000) 119-122
41. Remijn J.A., Wu Y.P., Jeninga E.H., Ljsseldijk M.J., van Willigen G., de Groot P.G., et al. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol 22 (2002) 686-691